Form 4: BioMarin Director Richard A. Meier Acquires 7,080 Shares of Common Stock
SEC Form 4
Director Richard A. Meier reported the acquisition of 7,080 shares of BioMarin Pharmaceutical Inc. common stock on May 21, 2024, through restricted stock units.
Summary
- On May 21, 2024, Richard A. Meier, a director of BioMarin Pharmaceutical Inc., acquired 7,080 shares of common stock.
- The acquisition was in the form of restricted stock units.
- Following the transaction, Meier beneficially owns 119,627 shares of BioMarin common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director, which doesn't inherently indicate positive or negative sentiment but suggests confidence.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.
Stakeholder Impact
- The acquisition of shares by a director may positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Date of transaction: Richard A. Meier acquired 7,080 shares of BioMarin common stock. |
| 05/23/2024 | Date of report: Form 4 filing date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.